ACKERMANN CHRISTINA 4
4 · Verona Pharma plc · Filed Nov 7, 2024
Insider Transaction Report
Form 4
ACKERMANN CHRISTINA
Director
Transactions
- Purchase
Ordinary Shares
2024-11-06$4.74/sh+41,880$198,386→ 41,880 total
Footnotes (2)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]Consists of 41,880 Ordinary Shares represented by 5,235 ADSs.